Isolation and identification of S. aureus and E. coli from subclinical mastitis milk samples
Milk samples collected from subclinical mastitis cases were used for the isolation of
S. aureus and
E. coli. Out of 45 collected samples, 25 samples had shown yellow colour colonies (mannitol fermenters) on mannitol salt agar and 8 samples have shown pink colour colonies (lactose fermenters) on MacConkey agar. On Gram’s staining, the colonies of mannitol fermenters appeared as Gram positive cocci arranged in clusters (
Staphylococcus sp.). The colonies of lactose fermenters appeared as Gram negative rods (
Coliform sp.).
Molecular identification of S. aureus and E. coli
Gram positive mannitol fermenters and Gram-negative lactose fermenters were subjected to molecular confirmation by PCR using species specific primers of
nuc gene for
S. aureus and
alr gene for
E. coli, respectively. Out of 25
Staphylococcus sp. and 8
coliform sp. subjected for PCR, 13 were found to be
S. aureus and 7 were found to be
E. coli (Fig 1 and 2).
Screening the isolates for biofilm formation
S. aureus and
E. coli isolated from subclinical mastitis cases were analyzed for biofilm formation by screening for the presence of biofilm associated genes and also phenotypic expression of biofilm formation on tissue culture plates.
PCR positive isolates of
S. aureus and
E. coli were further screened for the presence of biofilm associated genes by PCR using the primers targeted to
bap gene of
S. aureus and
ndvB gene of
E. coli. Out of 13
S. aureus and 7
E. coli isolates, 5 were positive for
bap gene and 4 were positive for
ndvB gene, respectively (Fig 3 and 4).
The isolates found positive for the presence of biofilm associated genes by PCR were further subjected to
in vitro biofilm assay using TCP method. Four out of five isolates of
S. aureus were found as strong biofilm producers while one was found to be moderate biofilm producer (Table 2). All the four isolates of
E. coli were strong biofilm producers (Table 3). From both
S. aureus and
E. coli isolates, top three biofilm producers were selected for full length amplification of
pfl gene by primer walking process using in-house designed primers.
Amplification of pfl gene of S. aureus and E. coli
Standardized PCR protocol was used for the amplification of
pfl gene of
S. aureus and
E. coli using three sets of respective overlapping primers. Amplified PCR products were analysed in 2% agarose gel electrophoresis and it had shown the expected product sizes of 830 bp, 851 bp and 783bp for
S. aureus and 849 bp, 810 bp and 899 bp for
E. coli as shown in Fig 5 (A, B, C) and Fig 6 (A, B, C) respectively.
The specificity of the PCR products was confirmed by custom sequence using forward and reverse primers separately. The sequenced results were subjected for BLAST analysis revealed 100% identity with the GenBank entries of
pfl gene sequences.
Reconstruction of full length pfl gene sequence of S. aureus and E. coli
The sequence of each amplicon was generated from both the directions based upon the sequence obtained from both forward and reverse primers. The entire length of coding region of
pfl gene sequence was reconstructed based on the overlapping sequence regions of individual
pfl amplicons using BioEdit sequence alignment editor (version 7.2.5) tool. The full length
pfl gene sequences were submitted in GenBank and accession numbers listed in Table 4.
Multiple sequence alignment of nucleotide sequence of pfl gene of S. aureus and E. coli
The coding region of
pfl sequence of each isolate of
S. aureus and
E. coli were subjected to multiple sequence alignment with reference to their respective reference sequence. In
S. aureus, a total of 16 mutations were observed, which corresponds to 11 nucleotide positions (Table 5). Out of 16 mutations in
S. aureus, 9 transition mutations and 7 transversion mutations were noticed. Similarly, in
E. coli, a total of 13 mutations were observed, which corresponds to 13 nucleotide positions (Table 6). Out of 13 mutations in
E. coli, 7 transition mutations and 6 transversion mutations were noticed.
Multiple sequence alignment of amino acid sequences
The entire coding region of the individual nucleotide sequence were subjected to
in silico translation using ExPASy Translate tool. The amino acid sequence of the PFL protein of the Puducherry isolates were subjected for multiple sequence alignment with their respective reference sequences using Clustal Omega server and the amino acid variations within the species were analysed. The identity score was predicted by multiple sequence alignment analysis using residue matches and each of the sequences were more than 99% of identity with the reference sequence. A total of 3 variations in
S. aureus isolates and 7 variations in
E. coli isolates were observed.
The codons corresponding to mutations and the details of amino acid variations for both
S. aureus and
E. coli were listed in Table 7 and Table 8. Out of 16 mutations of
S. aureus, 12 were synonymous mutations and 4 were nonsynonymous mutations whereas in
E. coli, out of 13 mutations, 6 were synonymous mutations and 7 were nonsynonymous mutations.
Protein structure prediction
The homology model prediction analysis was carried out using Swiss-Model server for the consensus sequence of PFL protein obtained by BioEdit sequence alignment editor (version 7.2.5) tool. In this study, PDB: IMZO.1. A. model was used as a parental template to model the PFL proteins of
S. aureus (Fig 7) and
E. coli (Fig 8).
The secondary structures were validated using Ramachandran plot analysis from MOLPROBITY server. Ramachandran plot analysis revealed that 94.3% and 98.6% of the residues were in the favored and allowed region for PFL protein of
S. aureus, respectively (Fig 9)
. Similarly, PFL protein of
E. coli had 95.3% and 99.8% of the residues in the favored and allowed region, respectively (Fig 10). Structural stability of PFL protein of both
S. aureus and
E. coli was analysed by Local Quality Estimate (Fig 11A and 11B) and QMEAN scoring (Fig 12A and 12B) revealed that all the amino acid residues are falling in narrow range (between 0 to 1.5) indicating predicted protein structures are highly stable.
The predicted models were visualized by Swiss-Model server for the 3D protein structures (Fig 13). Further 3D models were superimposed with their respective reference structures for the identification of structural alignment and the difference in folding pattern by UCSF chimera server. PFL protein of
S. aureus and
E. coli homology model structures were 99% superimposed with respect to their reference structures (Fig 14 and 15). Therefore, the homology models were highly stable and sharing similar domains with identical active site.
Primary PFL protein structure of
S. aureus and
E. coli revealed 66% identical with each other on Multiple sequence alignment (Clustal Omega) (Fig 16). PFL protein of
S. aureus and
E. coli were superimposed to study the structural similarities across the species by UCSF chimera tool. In spite of 66% identity in primary structure,
pfl proteins shared 85% of their tertiary structure on superimposing the homology models of (Fig 17A). The active sites are conserved in both the species with the two consécutive cysteine amino acids at 418, 419 positions in
E. coli and 413, 414 positions in
S. aureus with glycine residues at 734, 724 positions, in
E. coli and
S. aureus, respectively (Fig 17D). Two additional regions in
E. coli, “ENGVNL” and “FHHEA” corresponding to the positions 209-214 and 694-698 as showed in Fig 17B and Fig 17C forms a non-superimposed loop in the tertiary structure of superimposed structures of
S. aureus and
E. coli. The similar motif site residue “VASTITSHDAGY” which was present in both the sequences of
S. aureus and
E. coli were shown in Fig 17E. Likewise, several sites were matched highly between the PFL proteins among the two species.
Subclinical mastitis caused by bacterial pathogens such as
S. aureus and
E. coli remains a significant challenge in dairy production due to its persistent nature and impact on milk quality and animal health. The ability of these pathogens to form biofilms contributes substantially to their persistence within the host. Biofilm formation facilitates bacterial adhesion, protection from host immune responses and increased tolerance to antimicrobial agents, thereby promoting chronic infection.
Within the biofilm microenvironment, bacteria often encounter oxygen-limited conditions that necessitate metabolic adaptation for survival. Under such conditions, bacterial cells shift from aerobic metabolism to alternative anaerobic metabolic pathways. The
pfl gene encodes pyruvate formate lyase (PFL), a key enzyme involved in anaerobic metabolism that catalyzes the conversion of pyruvate to acetyl-CoA and formate. Previous studies have shown that
pfl expression is significantly increased under anaerobic conditions, indicating its role in supporting bacterial survival within biofilms
(Melchiorsen et al., 2002; Fuchs et al., 2007).
Sequence analysis of the
pfl gene among the selected isolates revealed the presence of nucleotide variations, although not all mutations resulted in amino acid substitutions. Synonymous mutations, while not altering the amino acid sequence, may still influence gene expression by affecting mRNA stability or translation efficiency (
Chamary and Hurst, 2005). Such variations may therefore contribute to regulatory differences in the expression or activity of the PFL enzyme.
Structural modelling of the PFL protein demonstrated that the predicted protein structures of both
S. aureus and
E. coli isolates were highly conserved when compared with their respective reference structures. Although differences were observed in the primary amino acid sequences between the two species, the tertiary structural organization remained highly similar. Importantly, the catalytic residues responsible for enzyme activity were conserved in both organisms, suggesting that the functional integrity of the enzyme is maintained despite sequence variability.
The conservation of the active site residues and overall structural stability of the PFL protein indicate that this enzyme plays a crucial role in bacterial metabolic adaptation during biofilm formation. Therefore, PFL may serve as a potential target for therapeutic strategies aimed at disrupting anaerobic metabolic pathways essential for bacterial survival within biofilms. Inhibition of PFL activity could impair biofilm-associated persistence of
S. aureus and
E. coli in subclinical mastitis, thereby improving treatment effectiveness and reducing the likelihood of recurrent infections.